                         SEQUENCE LISTING

<110>  Janssen Pharmaceutica NV	
       Protagonist Therapeutics, Inc.
 
<120>  Compositions of Peptide Inhibitors of Interleukin-23 Receptor

<130>  056365-518001WO

<140>  Herewith
<141>  Herewith

<150>  US 63/116,568
<151>  2020-11-20

<150>  US 63/275,222
<151>  2021-11-03

<160>  1   

<170>  PatentIn version 3.5


<210>  1
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic construct


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Pen

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is W(7-Me)

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Lys(Ac)

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Pen

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Phe is Phe[4-(2-aminoethoxy)]

<220>
<221>  MISC_FEATURE
<222>  (8)..(8)
<223>  Xaa is 2-Nal

<220>
<221>  MISC_FEATURE
<222>  (9)..(9)
<223>  Xaa is THP

<220>
<221>  MISC_FEATURE
<222>  (12)..(12)
<223>  Xaa is 3-Pal

<220>
<221>  MISC_FEATURE
<222>  (13)..(13)
<223>  Xaa is Sarc

<400>  1

Xaa Asn Thr Xaa Lys Xaa Phe Xaa Xaa Glu Asn Xaa Xaa 
1               5                   10              


